AMY FARMER: Open Payments
NPI 1588383574 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,503 in 156 payments from 19 companies in 2025. Trend: 2023 $2,058 · 2024 $2,512 · 2025 $2,503
Food & beverage: $2,503
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $688 |
| GENZYME CORPORATION | 11 | $248 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $199 |
| Ardelyx, Inc. | 12 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $165 |
| Aimmune Therapeutics, Inc. | 9 | $165 |
| Phathom Pharmaceuticals, Inc. | 11 | $142 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| QOL Medical, LLC | 5 | $93 |
| Lilly USA, LLC | 6 | $93 |
Products named: RINVOQ, DUPIXENT, XIFAXAN, IBSRELA, VOQUEZNA, TREMFYA, MAVYRET, LINZESS.
Industry payments across SC — which companies pay providers there.
